Swami Iyer, CPA
Seasoned Financial Executive with Expertise in the Pharmaceutical Industry
Professional Overview
Swami Iyer is a seasoned financial executive with over 20 years of experience in the pharmaceutical industry. As the current Chief Financial Officer (CFO) at Aurobindo Pharma USA, Inc., he leverages his deep expertise in financial management, strategic planning, and operational optimization to drive the company's financial success.
Experience Summary
Current Role
As the CFO at Aurobindo Pharma USA, Inc. since September 2022, Swami is responsible for overseeing the company's financial operations, including budgeting, forecasting, reporting, and risk management. He collaborates closely with the executive team to align financial strategies with the organization's overall business objectives, ensuring efficient resource allocation and profitability.
Career Progression
Prior to his current role, Swami held several senior finance positions within the pharmaceutical industry. He served as the Head of Finance at AUROLIFE PHARMA LLC, DAYTON, NJ08810 from 2009 to 2013, where he played a pivotal role in streamlining financial processes and driving cost optimization initiatives. Before that, he held the position of Vice President (Finance) at BIOLOGICAL E LTD from 2002 to 2008, where he was instrumental in implementing robust financial controls and improving the company's financial performance.
Academic Background
Swami holds a Bachelor's degree in Commerce and is a Certified Public Accountant (CPA), demonstrating his strong academic credentials and commitment to professional development.
Areas of Expertise
- Financial management and strategic planning
- Operational optimization and cost control
- Financial reporting and risk management
- Mergers, acquisitions, and integration
- Regulatory compliance and tax planning
- Leadership and team management
Professional Impact
Throughout his career, Swami has consistently demonstrated his ability to drive financial excellence and operational efficiency within the pharmaceutical industry. His leadership and strategic insights have contributed to the growth and profitability of the organizations he has worked for, positioning him as a trusted financial advisor and valued member of the executive team.
Conclusion
With his extensive experience, technical expertise, and proven track record of success, Swami Iyer is a highly respected financial executive in the pharmaceutical industry. As the CFO of Aurobindo Pharma USA, Inc., he is poised to continue making a significant impact, driving financial strategies that support the company's long-term growth and stability.